» Articles » PMID: 26791639

Neural Changes Developed During the Extinction of Cocaine Self-Administration Behavior

Overview
Publisher MDPI
Specialty Chemistry
Date 2016 Jan 22
PMID 26791639
Authors
Affiliations
Soon will be listed here.
Abstract

The high rate of recidivism in cocaine addiction after prolonged periods of abstinence poses a significant problem for the effective treatment of this condition. Moreover, the neurobiological basis of this relapse phenomenon remains poorly understood. In this review, we will discuss the evidence currently available regarding the neurobiological changes during the extinction of cocaine self-administration. Specifically, we will focus on alterations in the dopaminergic, opioidergic, glutamatergic, cholinergic, serotoninergic and CRF systems described in self-administration experiments and extinction studies after chronic cocaine administration. We will also discuss the differences related to contingent versus non-contingent cocaine administration, which highlights the importance of environmental cues on drug effects and extinction. The findings discussed in this review may aid the development of more effective therapeutic approaches to treat cocaine relapse.

References
1.
Crespo J, Manzanares J, Oliva J, Corchero J, Palomo T, Ambrosio E . Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology. 2001; 25(2):185-94. DOI: 10.1016/S0893-133X(01)00221-4. View

2.
Ahmed S . The science of making drug-addicted animals. Neuroscience. 2011; 211:107-25. DOI: 10.1016/j.neuroscience.2011.08.014. View

3.
Robinson T, Berridge K . Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008; 363(1507):3137-46. PMC: 2607325. DOI: 10.1098/rstb.2008.0093. View

4.
Malenka R, Bear M . LTP and LTD: an embarrassment of riches. Neuron. 2004; 44(1):5-21. DOI: 10.1016/j.neuron.2004.09.012. View

5.
Haney M . Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol. 2008; 14(1):9-21. PMC: 2743289. DOI: 10.1111/j.1369-1600.2008.00121.x. View